Brooks Automation (NASDAQ: BRKS), the biomedical equipment maker in Chelmsford, MA, says today it paid $79 million to acquire Nexus Biosystems, a suburban San Diego provider of compound sample management systems.
Based in Poway, CA, about 19 miles north of San Diego, Nexus makes automated equipment for handling chemical and biological samples in a variety of conditions and temperatures that is used worldwide in pharmaceutical, biotech, agrichemical, forensic, and research institutions. In addition to $79 million in cash, Brooks said it paid an additional $6.7 million for unrestricted cash that Nexus held at the closing.
Nexus Founder John Lillig, who started the company in 2005, was previously the chief technology officer at Discovery Partners International, a San Diego drug development company that merged in 2006 with Cambridge, MA-based Infinity Pharmaceuticals.
In a statement from Brooks, CEO Steve Schwartz says Nexus represents “an important next step” that will be combined with Brooks’ recent acquisition of RTS Life Sciences to extend its reach in the life sciences.